PLACID Trial Suggests Convalescent Plasma Does Not Reduce Mortality For COVID-19

Convalescent Plasma was not found to reduce mortality in patients suffering from COVID-19, found the PLACID trial conducted by the Indian Council of Medical Research. The study found that there was no significant difference in the progression of the disease irrespective of patients receiving or not receiving convalescent plasma. 

This is the first completed trial on convalescent plasma but still needs to be peer reviewed.